These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 662614)
21. [Ajmaline bitartrate in arrhythmias]. Szoenberg A; Samuel R; Friedman J; Sklerovsky S Harefuah; 1974 Jan; 86(2):70-5. PubMed ID: 4133115 [No Abstract] [Full Text] [Related]
22. [Ajmaline test in the diagnosis of paroxysmal atrioventricular block]. Guérot C; Coste A; Valère PE; Tricot R Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1241-53. PubMed ID: 4207469 [No Abstract] [Full Text] [Related]
23. [Drug-fever due to ajmaline (Tachmalin)]. Tausche P; Wunderlich E Z Gesamte Inn Med; 1976 Mar; 31(5):153-5. PubMed ID: 936705 [TBL] [Abstract][Full Text] [Related]
25. [Trial therapy with 3,4,5 trimethoxybenzoyl-epsilon-aminocaproic acid in acute myocardial infarct]. Selvini A; Belli C; Corallo S; Gramolini C; Ferrari ML G Ital Cardiol; 1973 May; 3(5):661-73. PubMed ID: 4589173 [No Abstract] [Full Text] [Related]
26. [Anti-arrhythmia therapy in emergencies--lidocaine versus ajmaline]. Löllgen H; Bausch R Z Gesamte Inn Med; 1991 Mar; 46(4):123-5. PubMed ID: 2058217 [TBL] [Abstract][Full Text] [Related]
27. [Agranulocytosis after use of aprindine (Fiboran)]. Poortermans JC; Majid PA; Roos JP Ned Tijdschr Geneeskd; 1976 Nov; 120(46):2011-2. PubMed ID: 1012364 [No Abstract] [Full Text] [Related]
28. [Life-threatening arrhythmias in a ajmaline treatment (Gilurytmal). A review on the pathogenesis, prevention and treatment]. Nielsen PB Ugeskr Laeger; 1980 Jul; 142(30):1917-20. PubMed ID: 6996262 [No Abstract] [Full Text] [Related]
29. [Ventricular fibrillation at the acute phase of myocardial infarction: prognosis after resuscitation]. Touche M; Touche S; Jouvet M; Trouve P Arch Mal Coeur Vaiss; 1973 Nov; 66(11):1435-41. PubMed ID: 4207487 [No Abstract] [Full Text] [Related]
30. [Clinical use of ajmaline]. Fomina IG Klin Med (Mosk); 1973 Nov; 51(11):9-15. PubMed ID: 4132418 [No Abstract] [Full Text] [Related]
31. [On rehabilitation of patients with myocardial infarct]. Nardelli A; Rulli V Cardiol Prat; 1973; 24(3):255-62. PubMed ID: 4779822 [No Abstract] [Full Text] [Related]
32. [The antiarrhythmic effect of intravenous 17-monochloroacetyl-ajmaline. A review of 50 treated cases]. Fiol Sala M Med Clin (Barc); 1983 Jun; 81(3):105-8. PubMed ID: 6888063 [No Abstract] [Full Text] [Related]
33. [The treatment of ventricular arrhythmias caused by myocardial infarct with xylocaine. Importance to recourse of electrosystolic pacing]. Bernard R; Stacquez A; Thys JP; Cornil A Mal Cardiovasc; 1969; 10(4):827-39. PubMed ID: 5405790 [No Abstract] [Full Text] [Related]
34. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)]. So CS; Oversohl K; Seidl KF Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646 [No Abstract] [Full Text] [Related]
35. [Effect of the class IA anti-arrhythmic agents ajmaline on end-systolic pressure-volume relations (conductance technique)]. Thormann J; Hüting J; Kremer P; Mitrovic V; Wissemann J; Bahawar H; Schlepper M Z Kardiol; 1990 Oct; 79(10):706-16. PubMed ID: 2087858 [TBL] [Abstract][Full Text] [Related]
36. [Acute renal insufficiency and ajmaline]. Godin M; Moulin B; Sery D; Fillastre JP Ann Med Interne (Paris); 1986; 137(2):167. PubMed ID: 3717822 [No Abstract] [Full Text] [Related]
37. [Oral therapy of cardiac arrhythmia using Neo-Gilurytmal (N-n-propyl-ajmalinium-hydrogentartrate)]. Mathey D; Bleifeld W; Effert S Med Klin; 1973 May; 68(18):598-601. PubMed ID: 4123381 [No Abstract] [Full Text] [Related]
38. [Profound granulocytopenia in a patient treated with propafenon ]. Mayrhofer EF; Davogg S; Feilhauer GD; Pilecky I; Seisenbacher H; Vockner H Wien Med Wochenschr; 1982 Jun; 132(11):273-5. PubMed ID: 7123969 [TBL] [Abstract][Full Text] [Related]